Abivax appoints Ana Sharma as Vice President, Global Head of Quality
PARIS, FRANCE: Abivax SA, a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in...
Abivax announces plans to conduct registered public offering in the United States
PARIS, FRANCE: Abivax, a French biotechnology company that develops novel treatments for inflammatory diseases, viral diseases and cancer, announced today that it intends to launch...